nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—hypertension—obesity	0.487	1	CtDrD
Doxazosin—ADRA1B—Phendimetrazine—obesity	0.0511	0.151	CbGbCtD
Doxazosin—ORM1—Bupropion—obesity	0.0435	0.128	CbGbCtD
Doxazosin—ADRA1A—Phendimetrazine—obesity	0.0403	0.119	CbGbCtD
Doxazosin—ADRA2A—Benzphetamine—obesity	0.0319	0.0941	CbGbCtD
Doxazosin—ADRA1A—Benzphetamine—obesity	0.0306	0.0903	CbGbCtD
Doxazosin—ADRA2A—Phenylpropanolamine—obesity	0.0304	0.0898	CbGbCtD
Doxazosin—ADRA1A—Phenylpropanolamine—obesity	0.0292	0.0861	CbGbCtD
Doxazosin—ADRA2A—Methamphetamine—obesity	0.0255	0.0753	CbGbCtD
Doxazosin—CYP2D6—Phentermine—obesity	0.0106	0.0313	CbGbCtD
Doxazosin—CYP2D6—Bupropion—obesity	0.00901	0.0266	CbGbCtD
Doxazosin—CYP2C19—Cimetidine—obesity	0.0087	0.0257	CbGbCtD
Doxazosin—CYP2D6—Methamphetamine—obesity	0.00848	0.025	CbGbCtD
Doxazosin—ABCB1—Cimetidine—obesity	0.00702	0.0207	CbGbCtD
Doxazosin—CYP2D6—Cimetidine—obesity	0.00662	0.0195	CbGbCtD
Doxazosin—CYP2C19—Topiramate—obesity	0.0057	0.0168	CbGbCtD
Doxazosin—ORM1—bile—obesity	0.00204	0.273	CbGeAlD
Doxazosin—Donepezil—HRH3—obesity	0.00122	0.633	CrCbGaD
Doxazosin—ORM1—gall bladder—obesity	0.000567	0.0758	CbGeAlD
Doxazosin—Prazosin—SLC22A1—obesity	0.00043	0.222	CrCbGaD
Doxazosin—ADRA1A—hindbrain—obesity	0.000401	0.0536	CbGeAlD
Doxazosin—Donepezil—HTR2A—obesity	0.000279	0.144	CrCbGaD
Doxazosin—KCNH2—islet of Langerhans—obesity	0.00025	0.0335	CbGeAlD
Doxazosin—CYP2D6—hindbrain—obesity	0.000236	0.0316	CbGeAlD
Doxazosin—ADRA1D—endocrine gland—obesity	0.000224	0.0299	CbGeAlD
Doxazosin—ADRA2A—islet of Langerhans—obesity	0.000197	0.0264	CbGeAlD
Doxazosin—ADRA1A—cardiovascular system—obesity	0.000187	0.0251	CbGeAlD
Doxazosin—ORM1—endocrine gland—obesity	0.000184	0.0247	CbGeAlD
Doxazosin—KCNH2—cardiovascular system—obesity	0.000181	0.0242	CbGeAlD
Doxazosin—ORM1—liver—obesity	0.000166	0.0222	CbGeAlD
Doxazosin—ADRA1A—adipose tissue—obesity	0.000165	0.0221	CbGeAlD
Doxazosin—KCNH2—pituitary gland—obesity	0.00016	0.0214	CbGeAlD
Doxazosin—CYP2C19—digestive system—obesity	0.000157	0.0211	CbGeAlD
Doxazosin—ADRA1A—adrenal gland—obesity	0.000148	0.0198	CbGeAlD
Doxazosin—KCNH2—adrenal gland—obesity	0.000143	0.0191	CbGeAlD
Doxazosin—CYP2C19—endocrine gland—obesity	0.00013	0.0174	CbGeAlD
Doxazosin—ADRA1A—endocrine gland—obesity	0.000129	0.0172	CbGeAlD
Doxazosin—ADRA2A—pituitary gland—obesity	0.000126	0.0169	CbGeAlD
Doxazosin—ADRA2A—adipose tissue—obesity	0.000126	0.0168	CbGeAlD
Doxazosin—KCNH2—endocrine gland—obesity	0.000124	0.0166	CbGeAlD
Doxazosin—CYP2C19—liver—obesity	0.000117	0.0157	CbGeAlD
Doxazosin—ADRA1A—liver—obesity	0.000116	0.0155	CbGeAlD
Doxazosin—ADRA2A—adrenal gland—obesity	0.000113	0.0151	CbGeAlD
Doxazosin—ABCB1—islet of Langerhans—obesity	0.00011	0.0147	CbGeAlD
Doxazosin—ABCB1—respiratory system—obesity	0.000104	0.0139	CbGeAlD
Doxazosin—ADRA2A—endocrine gland—obesity	9.77e-05	0.0131	CbGeAlD
Doxazosin—CYP2D6—digestive system—obesity	9.16e-05	0.0123	CbGeAlD
Doxazosin—ABCB1—adrenal cortex—obesity	8.7e-05	0.0116	CbGeAlD
Doxazosin—Malaise—Sibutramine—obesity	8.05e-05	0.000756	CcSEcCtD
Doxazosin—Cough—Orlistat—obesity	8.05e-05	0.000756	CcSEcCtD
Doxazosin—Chills—Bupropion—obesity	8.02e-05	0.000754	CcSEcCtD
Doxazosin—Vertigo—Sibutramine—obesity	8.02e-05	0.000754	CcSEcCtD
Doxazosin—Syncope—Sibutramine—obesity	8.01e-05	0.000752	CcSEcCtD
Doxazosin—Convulsion—Orlistat—obesity	7.99e-05	0.000751	CcSEcCtD
Doxazosin—Leukopenia—Sibutramine—obesity	7.99e-05	0.000751	CcSEcCtD
Doxazosin—Arrhythmia—Bupropion—obesity	7.99e-05	0.00075	CcSEcCtD
Doxazosin—Face oedema—Topiramate—obesity	7.95e-05	0.000747	CcSEcCtD
Doxazosin—ABCB1—cardiovascular system—obesity	7.94e-05	0.0106	CbGeAlD
Doxazosin—Alopecia—Bupropion—obesity	7.9e-05	0.000742	CcSEcCtD
Doxazosin—Palpitations—Sibutramine—obesity	7.89e-05	0.000741	CcSEcCtD
Doxazosin—Chest pain—Orlistat—obesity	7.86e-05	0.000738	CcSEcCtD
Doxazosin—Myalgia—Orlistat—obesity	7.86e-05	0.000738	CcSEcCtD
Doxazosin—Loss of consciousness—Sibutramine—obesity	7.85e-05	0.000737	CcSEcCtD
Doxazosin—Mental disorder—Bupropion—obesity	7.83e-05	0.000736	CcSEcCtD
Doxazosin—Urinary retention—Topiramate—obesity	7.83e-05	0.000736	CcSEcCtD
Doxazosin—Anxiety—Orlistat—obesity	7.83e-05	0.000735	CcSEcCtD
Doxazosin—Mood swings—Topiramate—obesity	7.8e-05	0.000733	CcSEcCtD
Doxazosin—Cough—Sibutramine—obesity	7.79e-05	0.000732	CcSEcCtD
Doxazosin—Malnutrition—Bupropion—obesity	7.78e-05	0.000731	CcSEcCtD
Doxazosin—Discomfort—Orlistat—obesity	7.76e-05	0.000729	CcSEcCtD
Doxazosin—Ataxia—Topiramate—obesity	7.74e-05	0.000727	CcSEcCtD
Doxazosin—Convulsion—Sibutramine—obesity	7.74e-05	0.000727	CcSEcCtD
Doxazosin—Hypertension—Sibutramine—obesity	7.71e-05	0.000724	CcSEcCtD
Doxazosin—Dry mouth—Orlistat—obesity	7.68e-05	0.000722	CcSEcCtD
Doxazosin—Flatulence—Bupropion—obesity	7.67e-05	0.000721	CcSEcCtD
Doxazosin—Dehydration—Topiramate—obesity	7.66e-05	0.000719	CcSEcCtD
Doxazosin—Tension—Bupropion—obesity	7.64e-05	0.000718	CcSEcCtD
Doxazosin—Dysgeusia—Bupropion—obesity	7.62e-05	0.000716	CcSEcCtD
Doxazosin—Liver function test abnormal—Topiramate—obesity	7.6e-05	0.000714	CcSEcCtD
Doxazosin—Chest pain—Sibutramine—obesity	7.6e-05	0.000714	CcSEcCtD
Doxazosin—Arthralgia—Sibutramine—obesity	7.6e-05	0.000714	CcSEcCtD
Doxazosin—Myalgia—Sibutramine—obesity	7.6e-05	0.000714	CcSEcCtD
Doxazosin—Anxiety—Sibutramine—obesity	7.58e-05	0.000712	CcSEcCtD
Doxazosin—CYP2D6—endocrine gland—obesity	7.57e-05	0.0101	CbGeAlD
Doxazosin—Nervousness—Bupropion—obesity	7.56e-05	0.00071	CcSEcCtD
Doxazosin—Oedema—Orlistat—obesity	7.53e-05	0.000707	CcSEcCtD
Doxazosin—Back pain—Bupropion—obesity	7.53e-05	0.000707	CcSEcCtD
Doxazosin—Orthostatic hypotension—Topiramate—obesity	7.52e-05	0.000707	CcSEcCtD
Doxazosin—Discomfort—Sibutramine—obesity	7.51e-05	0.000706	CcSEcCtD
Doxazosin—Hypokalaemia—Topiramate—obesity	7.5e-05	0.000704	CcSEcCtD
Doxazosin—Muscle spasms—Bupropion—obesity	7.48e-05	0.000703	CcSEcCtD
Doxazosin—Infection—Orlistat—obesity	7.48e-05	0.000703	CcSEcCtD
Doxazosin—Dry mouth—Sibutramine—obesity	7.44e-05	0.000698	CcSEcCtD
Doxazosin—Confusional state—Sibutramine—obesity	7.35e-05	0.00069	CcSEcCtD
Doxazosin—Vision blurred—Bupropion—obesity	7.34e-05	0.000689	CcSEcCtD
Doxazosin—Skin disorder—Orlistat—obesity	7.31e-05	0.000687	CcSEcCtD
Doxazosin—Tremor—Bupropion—obesity	7.29e-05	0.000685	CcSEcCtD
Doxazosin—Oedema—Sibutramine—obesity	7.29e-05	0.000685	CcSEcCtD
Doxazosin—Hyperhidrosis—Orlistat—obesity	7.28e-05	0.000684	CcSEcCtD
Doxazosin—Muscular weakness—Topiramate—obesity	7.26e-05	0.000682	CcSEcCtD
Doxazosin—Infection—Sibutramine—obesity	7.24e-05	0.00068	CcSEcCtD
Doxazosin—Ill-defined disorder—Bupropion—obesity	7.22e-05	0.000678	CcSEcCtD
Doxazosin—Shock—Sibutramine—obesity	7.17e-05	0.000673	CcSEcCtD
Doxazosin—Abdominal distension—Topiramate—obesity	7.17e-05	0.000673	CcSEcCtD
Doxazosin—Agitation—Bupropion—obesity	7.15e-05	0.000672	CcSEcCtD
Doxazosin—Thrombocytopenia—Sibutramine—obesity	7.14e-05	0.00067	CcSEcCtD
Doxazosin—Tachycardia—Sibutramine—obesity	7.11e-05	0.000668	CcSEcCtD
Doxazosin—Skin disorder—Sibutramine—obesity	7.08e-05	0.000665	CcSEcCtD
Doxazosin—Hyperhidrosis—Sibutramine—obesity	7.05e-05	0.000662	CcSEcCtD
Doxazosin—ABCB1—pituitary gland—obesity	7.03e-05	0.0094	CbGeAlD
Doxazosin—Malaise—Bupropion—obesity	7.02e-05	0.000659	CcSEcCtD
Doxazosin—ABCB1—adipose tissue—obesity	7e-05	0.00937	CbGeAlD
Doxazosin—Vertigo—Bupropion—obesity	6.99e-05	0.000657	CcSEcCtD
Doxazosin—Syncope—Bupropion—obesity	6.98e-05	0.000656	CcSEcCtD
Doxazosin—Leukopenia—Bupropion—obesity	6.97e-05	0.000655	CcSEcCtD
Doxazosin—Anorexia—Sibutramine—obesity	6.95e-05	0.000653	CcSEcCtD
Doxazosin—Sweating increased—Topiramate—obesity	6.93e-05	0.000651	CcSEcCtD
Doxazosin—Angina pectoris—Topiramate—obesity	6.93e-05	0.000651	CcSEcCtD
Doxazosin—Palpitations—Bupropion—obesity	6.88e-05	0.000646	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Orlistat—obesity	6.86e-05	0.000644	CcSEcCtD
Doxazosin—Bronchitis—Topiramate—obesity	6.85e-05	0.000643	CcSEcCtD
Doxazosin—Loss of consciousness—Bupropion—obesity	6.84e-05	0.000643	CcSEcCtD
Doxazosin—CYP2D6—liver—obesity	6.83e-05	0.00913	CbGeAlD
Doxazosin—Abdominal discomfort—Topiramate—obesity	6.82e-05	0.000641	CcSEcCtD
Doxazosin—Insomnia—Orlistat—obesity	6.81e-05	0.00064	CcSEcCtD
Doxazosin—Hypotension—Sibutramine—obesity	6.81e-05	0.00064	CcSEcCtD
Doxazosin—Cough—Bupropion—obesity	6.79e-05	0.000638	CcSEcCtD
Doxazosin—Paraesthesia—Orlistat—obesity	6.76e-05	0.000635	CcSEcCtD
Doxazosin—Convulsion—Bupropion—obesity	6.75e-05	0.000634	CcSEcCtD
Doxazosin—Hypertension—Bupropion—obesity	6.72e-05	0.000631	CcSEcCtD
Doxazosin—Dysuria—Topiramate—obesity	6.66e-05	0.000625	CcSEcCtD
Doxazosin—Neutropenia—Topiramate—obesity	6.66e-05	0.000625	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Sibutramine—obesity	6.64e-05	0.000624	CcSEcCtD
Doxazosin—Dyspepsia—Orlistat—obesity	6.63e-05	0.000623	CcSEcCtD
Doxazosin—Myalgia—Bupropion—obesity	6.63e-05	0.000623	CcSEcCtD
Doxazosin—Chest pain—Bupropion—obesity	6.63e-05	0.000623	CcSEcCtD
Doxazosin—Arthralgia—Bupropion—obesity	6.63e-05	0.000623	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Topiramate—obesity	6.62e-05	0.000621	CcSEcCtD
Doxazosin—Anxiety—Bupropion—obesity	6.6e-05	0.00062	CcSEcCtD
Doxazosin—Insomnia—Sibutramine—obesity	6.59e-05	0.000619	CcSEcCtD
Doxazosin—ABCB1—digestive system—obesity	6.59e-05	0.00882	CbGeAlD
Doxazosin—Pollakiuria—Topiramate—obesity	6.58e-05	0.000618	CcSEcCtD
Doxazosin—Erectile dysfunction—Topiramate—obesity	6.56e-05	0.000616	CcSEcCtD
Doxazosin—Discomfort—Bupropion—obesity	6.55e-05	0.000615	CcSEcCtD
Doxazosin—Decreased appetite—Orlistat—obesity	6.55e-05	0.000615	CcSEcCtD
Doxazosin—Paraesthesia—Sibutramine—obesity	6.54e-05	0.000615	CcSEcCtD
Doxazosin—Dyspnoea—Sibutramine—obesity	6.5e-05	0.00061	CcSEcCtD
Doxazosin—Photosensitivity reaction—Topiramate—obesity	6.5e-05	0.00061	CcSEcCtD
Doxazosin—Fatigue—Orlistat—obesity	6.49e-05	0.00061	CcSEcCtD
Doxazosin—Dry mouth—Bupropion—obesity	6.48e-05	0.000609	CcSEcCtD
Doxazosin—Somnolence—Sibutramine—obesity	6.48e-05	0.000609	CcSEcCtD
Doxazosin—Weight increased—Topiramate—obesity	6.48e-05	0.000608	CcSEcCtD
Doxazosin—Weight decreased—Topiramate—obesity	6.44e-05	0.000605	CcSEcCtD
Doxazosin—Pain—Orlistat—obesity	6.44e-05	0.000605	CcSEcCtD
Doxazosin—Hyperglycaemia—Topiramate—obesity	6.42e-05	0.000603	CcSEcCtD
Doxazosin—Dyspepsia—Sibutramine—obesity	6.42e-05	0.000603	CcSEcCtD
Doxazosin—Confusional state—Bupropion—obesity	6.41e-05	0.000602	CcSEcCtD
Doxazosin—Pneumonia—Topiramate—obesity	6.38e-05	0.0006	CcSEcCtD
Doxazosin—Oedema—Bupropion—obesity	6.35e-05	0.000597	CcSEcCtD
Doxazosin—Decreased appetite—Sibutramine—obesity	6.34e-05	0.000595	CcSEcCtD
Doxazosin—Depression—Topiramate—obesity	6.33e-05	0.000594	CcSEcCtD
Doxazosin—Infection—Bupropion—obesity	6.31e-05	0.000593	CcSEcCtD
Doxazosin—ABCB1—adrenal gland—obesity	6.28e-05	0.0084	CbGeAlD
Doxazosin—Shock—Bupropion—obesity	6.25e-05	0.000587	CcSEcCtD
Doxazosin—Constipation—Sibutramine—obesity	6.23e-05	0.000585	CcSEcCtD
Doxazosin—Pain—Sibutramine—obesity	6.23e-05	0.000585	CcSEcCtD
Doxazosin—Thrombocytopenia—Bupropion—obesity	6.22e-05	0.000584	CcSEcCtD
Doxazosin—Feeling abnormal—Orlistat—obesity	6.21e-05	0.000583	CcSEcCtD
Doxazosin—Tachycardia—Bupropion—obesity	6.2e-05	0.000582	CcSEcCtD
Doxazosin—Skin disorder—Bupropion—obesity	6.17e-05	0.00058	CcSEcCtD
Doxazosin—Urinary tract infection—Topiramate—obesity	6.17e-05	0.000579	CcSEcCtD
Doxazosin—Conjunctivitis—Topiramate—obesity	6.17e-05	0.000579	CcSEcCtD
Doxazosin—Gastrointestinal pain—Orlistat—obesity	6.16e-05	0.000578	CcSEcCtD
Doxazosin—Hyperhidrosis—Bupropion—obesity	6.14e-05	0.000577	CcSEcCtD
Doxazosin—Anorexia—Bupropion—obesity	6.06e-05	0.000569	CcSEcCtD
Doxazosin—Haematuria—Topiramate—obesity	6.05e-05	0.000568	CcSEcCtD
Doxazosin—Feeling abnormal—Sibutramine—obesity	6.01e-05	0.000564	CcSEcCtD
Doxazosin—Epistaxis—Topiramate—obesity	5.99e-05	0.000562	CcSEcCtD
Doxazosin—Urticaria—Orlistat—obesity	5.98e-05	0.000562	CcSEcCtD
Doxazosin—Gastrointestinal pain—Sibutramine—obesity	5.96e-05	0.00056	CcSEcCtD
Doxazosin—Sinusitis—Topiramate—obesity	5.95e-05	0.000559	CcSEcCtD
Doxazosin—Abdominal pain—Orlistat—obesity	5.95e-05	0.000559	CcSEcCtD
Doxazosin—Body temperature increased—Orlistat—obesity	5.95e-05	0.000559	CcSEcCtD
Doxazosin—Hypotension—Bupropion—obesity	5.94e-05	0.000558	CcSEcCtD
Doxazosin—Bradycardia—Topiramate—obesity	5.8e-05	0.000545	CcSEcCtD
Doxazosin—Urticaria—Sibutramine—obesity	5.79e-05	0.000544	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Bupropion—obesity	5.79e-05	0.000544	CcSEcCtD
Doxazosin—Body temperature increased—Sibutramine—obesity	5.76e-05	0.000541	CcSEcCtD
Doxazosin—Abdominal pain—Sibutramine—obesity	5.76e-05	0.000541	CcSEcCtD
Doxazosin—Insomnia—Bupropion—obesity	5.75e-05	0.00054	CcSEcCtD
Doxazosin—Rhinitis—Topiramate—obesity	5.71e-05	0.000537	CcSEcCtD
Doxazosin—Paraesthesia—Bupropion—obesity	5.71e-05	0.000536	CcSEcCtD
Doxazosin—Hepatitis—Topiramate—obesity	5.7e-05	0.000535	CcSEcCtD
Doxazosin—Hypoaesthesia—Topiramate—obesity	5.67e-05	0.000532	CcSEcCtD
Doxazosin—Dyspnoea—Bupropion—obesity	5.66e-05	0.000532	CcSEcCtD
Doxazosin—Pharyngitis—Topiramate—obesity	5.65e-05	0.000531	CcSEcCtD
Doxazosin—Somnolence—Bupropion—obesity	5.65e-05	0.000531	CcSEcCtD
Doxazosin—Dyspepsia—Bupropion—obesity	5.59e-05	0.000525	CcSEcCtD
Doxazosin—Hypersensitivity—Orlistat—obesity	5.55e-05	0.000521	CcSEcCtD
Doxazosin—Decreased appetite—Bupropion—obesity	5.52e-05	0.000519	CcSEcCtD
Doxazosin—Visual impairment—Topiramate—obesity	5.49e-05	0.000516	CcSEcCtD
Doxazosin—Fatigue—Bupropion—obesity	5.48e-05	0.000515	CcSEcCtD
Doxazosin—ABCB1—endocrine gland—obesity	5.45e-05	0.00728	CbGeAlD
Doxazosin—Pain—Bupropion—obesity	5.43e-05	0.00051	CcSEcCtD
Doxazosin—Constipation—Bupropion—obesity	5.43e-05	0.00051	CcSEcCtD
Doxazosin—Asthenia—Orlistat—obesity	5.4e-05	0.000507	CcSEcCtD
Doxazosin—Hypersensitivity—Sibutramine—obesity	5.37e-05	0.000504	CcSEcCtD
Doxazosin—Pruritus—Orlistat—obesity	5.33e-05	0.0005	CcSEcCtD
Doxazosin—Eye disorder—Topiramate—obesity	5.32e-05	0.0005	CcSEcCtD
Doxazosin—Tinnitus—Topiramate—obesity	5.31e-05	0.000499	CcSEcCtD
Doxazosin—Flushing—Topiramate—obesity	5.29e-05	0.000497	CcSEcCtD
Doxazosin—Feeling abnormal—Bupropion—obesity	5.24e-05	0.000492	CcSEcCtD
Doxazosin—Asthenia—Sibutramine—obesity	5.23e-05	0.000491	CcSEcCtD
Doxazosin—Gastrointestinal pain—Bupropion—obesity	5.2e-05	0.000488	CcSEcCtD
Doxazosin—Pruritus—Sibutramine—obesity	5.16e-05	0.000484	CcSEcCtD
Doxazosin—Diarrhoea—Orlistat—obesity	5.15e-05	0.000484	CcSEcCtD
Doxazosin—Chills—Topiramate—obesity	5.11e-05	0.00048	CcSEcCtD
Doxazosin—Urticaria—Bupropion—obesity	5.05e-05	0.000474	CcSEcCtD
Doxazosin—Alopecia—Topiramate—obesity	5.03e-05	0.000473	CcSEcCtD
Doxazosin—Body temperature increased—Bupropion—obesity	5.02e-05	0.000472	CcSEcCtD
Doxazosin—Abdominal pain—Bupropion—obesity	5.02e-05	0.000472	CcSEcCtD
Doxazosin—Mental disorder—Topiramate—obesity	4.99e-05	0.000469	CcSEcCtD
Doxazosin—Diarrhoea—Sibutramine—obesity	4.99e-05	0.000468	CcSEcCtD
Doxazosin—Dizziness—Orlistat—obesity	4.98e-05	0.000468	CcSEcCtD
Doxazosin—Malnutrition—Topiramate—obesity	4.96e-05	0.000466	CcSEcCtD
Doxazosin—ABCB1—liver—obesity	4.91e-05	0.00657	CbGeAlD
Doxazosin—Flatulence—Topiramate—obesity	4.89e-05	0.000459	CcSEcCtD
Doxazosin—Tension—Topiramate—obesity	4.87e-05	0.000457	CcSEcCtD
Doxazosin—Dysgeusia—Topiramate—obesity	4.86e-05	0.000456	CcSEcCtD
Doxazosin—Dizziness—Sibutramine—obesity	4.82e-05	0.000453	CcSEcCtD
Doxazosin—Nervousness—Topiramate—obesity	4.82e-05	0.000452	CcSEcCtD
Doxazosin—Back pain—Topiramate—obesity	4.8e-05	0.000451	CcSEcCtD
Doxazosin—Vomiting—Orlistat—obesity	4.79e-05	0.00045	CcSEcCtD
Doxazosin—Muscle spasms—Topiramate—obesity	4.77e-05	0.000448	CcSEcCtD
Doxazosin—Rash—Orlistat—obesity	4.75e-05	0.000446	CcSEcCtD
Doxazosin—Dermatitis—Orlistat—obesity	4.74e-05	0.000446	CcSEcCtD
Doxazosin—Headache—Orlistat—obesity	4.72e-05	0.000443	CcSEcCtD
Doxazosin—Hypersensitivity—Bupropion—obesity	4.68e-05	0.00044	CcSEcCtD
Doxazosin—Vision blurred—Topiramate—obesity	4.67e-05	0.000439	CcSEcCtD
Doxazosin—Tremor—Topiramate—obesity	4.65e-05	0.000436	CcSEcCtD
Doxazosin—Vomiting—Sibutramine—obesity	4.63e-05	0.000435	CcSEcCtD
Doxazosin—Ill-defined disorder—Topiramate—obesity	4.6e-05	0.000432	CcSEcCtD
Doxazosin—Rash—Sibutramine—obesity	4.6e-05	0.000432	CcSEcCtD
Doxazosin—Dermatitis—Sibutramine—obesity	4.59e-05	0.000431	CcSEcCtD
Doxazosin—Headache—Sibutramine—obesity	4.57e-05	0.000429	CcSEcCtD
Doxazosin—Asthenia—Bupropion—obesity	4.56e-05	0.000428	CcSEcCtD
Doxazosin—Agitation—Topiramate—obesity	4.56e-05	0.000428	CcSEcCtD
Doxazosin—Pruritus—Bupropion—obesity	4.5e-05	0.000422	CcSEcCtD
Doxazosin—Nausea—Orlistat—obesity	4.47e-05	0.00042	CcSEcCtD
Doxazosin—Malaise—Topiramate—obesity	4.47e-05	0.00042	CcSEcCtD
Doxazosin—Vertigo—Topiramate—obesity	4.46e-05	0.000419	CcSEcCtD
Doxazosin—Syncope—Topiramate—obesity	4.45e-05	0.000418	CcSEcCtD
Doxazosin—Leukopenia—Topiramate—obesity	4.44e-05	0.000417	CcSEcCtD
Doxazosin—Palpitations—Topiramate—obesity	4.38e-05	0.000412	CcSEcCtD
Doxazosin—Loss of consciousness—Topiramate—obesity	4.36e-05	0.000409	CcSEcCtD
Doxazosin—Diarrhoea—Bupropion—obesity	4.35e-05	0.000408	CcSEcCtD
Doxazosin—Nausea—Sibutramine—obesity	4.33e-05	0.000407	CcSEcCtD
Doxazosin—Cough—Topiramate—obesity	4.33e-05	0.000407	CcSEcCtD
Doxazosin—Convulsion—Topiramate—obesity	4.3e-05	0.000404	CcSEcCtD
Doxazosin—Hypertension—Topiramate—obesity	4.28e-05	0.000402	CcSEcCtD
Doxazosin—Arthralgia—Topiramate—obesity	4.22e-05	0.000397	CcSEcCtD
Doxazosin—Chest pain—Topiramate—obesity	4.22e-05	0.000397	CcSEcCtD
Doxazosin—Myalgia—Topiramate—obesity	4.22e-05	0.000397	CcSEcCtD
Doxazosin—Anxiety—Topiramate—obesity	4.21e-05	0.000395	CcSEcCtD
Doxazosin—Dizziness—Bupropion—obesity	4.2e-05	0.000395	CcSEcCtD
Doxazosin—Discomfort—Topiramate—obesity	4.17e-05	0.000392	CcSEcCtD
Doxazosin—Dry mouth—Topiramate—obesity	4.13e-05	0.000388	CcSEcCtD
Doxazosin—Confusional state—Topiramate—obesity	4.08e-05	0.000383	CcSEcCtD
Doxazosin—Oedema—Topiramate—obesity	4.05e-05	0.00038	CcSEcCtD
Doxazosin—Vomiting—Bupropion—obesity	4.04e-05	0.000379	CcSEcCtD
Doxazosin—Infection—Topiramate—obesity	4.02e-05	0.000378	CcSEcCtD
Doxazosin—Rash—Bupropion—obesity	4.01e-05	0.000376	CcSEcCtD
Doxazosin—Dermatitis—Bupropion—obesity	4e-05	0.000376	CcSEcCtD
Doxazosin—Shock—Topiramate—obesity	3.98e-05	0.000374	CcSEcCtD
Doxazosin—Headache—Bupropion—obesity	3.98e-05	0.000374	CcSEcCtD
Doxazosin—Thrombocytopenia—Topiramate—obesity	3.96e-05	0.000372	CcSEcCtD
Doxazosin—Tachycardia—Topiramate—obesity	3.95e-05	0.000371	CcSEcCtD
Doxazosin—Skin disorder—Topiramate—obesity	3.93e-05	0.000369	CcSEcCtD
Doxazosin—Hyperhidrosis—Topiramate—obesity	3.91e-05	0.000368	CcSEcCtD
Doxazosin—Anorexia—Topiramate—obesity	3.86e-05	0.000362	CcSEcCtD
Doxazosin—Hypotension—Topiramate—obesity	3.78e-05	0.000355	CcSEcCtD
Doxazosin—Nausea—Bupropion—obesity	3.77e-05	0.000354	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Topiramate—obesity	3.69e-05	0.000346	CcSEcCtD
Doxazosin—Insomnia—Topiramate—obesity	3.66e-05	0.000344	CcSEcCtD
Doxazosin—Paraesthesia—Topiramate—obesity	3.63e-05	0.000341	CcSEcCtD
Doxazosin—Dyspnoea—Topiramate—obesity	3.61e-05	0.000339	CcSEcCtD
Doxazosin—Somnolence—Topiramate—obesity	3.6e-05	0.000338	CcSEcCtD
Doxazosin—Dyspepsia—Topiramate—obesity	3.56e-05	0.000335	CcSEcCtD
Doxazosin—Decreased appetite—Topiramate—obesity	3.52e-05	0.000331	CcSEcCtD
Doxazosin—Fatigue—Topiramate—obesity	3.49e-05	0.000328	CcSEcCtD
Doxazosin—Pain—Topiramate—obesity	3.46e-05	0.000325	CcSEcCtD
Doxazosin—Constipation—Topiramate—obesity	3.46e-05	0.000325	CcSEcCtD
Doxazosin—Feeling abnormal—Topiramate—obesity	3.34e-05	0.000313	CcSEcCtD
Doxazosin—Gastrointestinal pain—Topiramate—obesity	3.31e-05	0.000311	CcSEcCtD
Doxazosin—Urticaria—Topiramate—obesity	3.22e-05	0.000302	CcSEcCtD
Doxazosin—Abdominal pain—Topiramate—obesity	3.2e-05	0.000301	CcSEcCtD
Doxazosin—Body temperature increased—Topiramate—obesity	3.2e-05	0.000301	CcSEcCtD
Doxazosin—Hypersensitivity—Topiramate—obesity	2.98e-05	0.00028	CcSEcCtD
Doxazosin—Asthenia—Topiramate—obesity	2.9e-05	0.000273	CcSEcCtD
Doxazosin—Pruritus—Topiramate—obesity	2.86e-05	0.000269	CcSEcCtD
Doxazosin—Diarrhoea—Topiramate—obesity	2.77e-05	0.00026	CcSEcCtD
Doxazosin—Dizziness—Topiramate—obesity	2.68e-05	0.000251	CcSEcCtD
Doxazosin—Vomiting—Topiramate—obesity	2.57e-05	0.000242	CcSEcCtD
Doxazosin—Rash—Topiramate—obesity	2.55e-05	0.00024	CcSEcCtD
Doxazosin—Dermatitis—Topiramate—obesity	2.55e-05	0.00024	CcSEcCtD
Doxazosin—Headache—Topiramate—obesity	2.54e-05	0.000238	CcSEcCtD
Doxazosin—Nausea—Topiramate—obesity	2.4e-05	0.000226	CcSEcCtD
Doxazosin—ADRA1B—Signaling Pathways—CAV1—obesity	2.28e-06	3.91e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NCOA1—obesity	2.28e-06	3.91e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOA1—obesity	2.27e-06	3.9e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—obesity	2.27e-06	3.9e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LPL—obesity	2.26e-06	3.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CAV1—obesity	2.25e-06	3.86e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCG—obesity	2.25e-06	3.86e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A4—obesity	2.25e-06	3.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FOXO1—obesity	2.25e-06	3.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCD—obesity	2.24e-06	3.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RPS6KB1—obesity	2.24e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOA1—obesity	2.24e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP19A1—obesity	2.24e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—STK11—obesity	2.24e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CB—obesity	2.22e-06	3.82e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYCS—obesity	2.22e-06	3.81e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CD—obesity	2.2e-06	3.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—obesity	2.2e-06	3.77e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—obesity	2.2e-06	3.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—C3—obesity	2.19e-06	3.77e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GGT1—obesity	2.18e-06	3.74e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT1—obesity	2.18e-06	3.74e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	2.18e-06	3.74e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—obesity	2.17e-06	3.73e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—F2—obesity	2.17e-06	3.72e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PRKCB—obesity	2.17e-06	3.72e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NCOA1—obesity	2.14e-06	3.68e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BAD—obesity	2.14e-06	3.68e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—COMT—obesity	2.14e-06	3.67e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TYK2—obesity	2.11e-06	3.63e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—STK11—obesity	2.11e-06	3.63e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP19A1—obesity	2.11e-06	3.63e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNB3—obesity	2.11e-06	3.62e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARGC1A—obesity	2.11e-06	3.62e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—obesity	2.1e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RHOA—obesity	2.1e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS2—obesity	2.09e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCD—obesity	2.09e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—COMT—obesity	2.09e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—obesity	2.08e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3R1—obesity	2.08e-06	3.56e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—obesity	2.08e-06	3.56e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—obesity	2.07e-06	3.56e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARGC1A—obesity	2.06e-06	3.53e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNB3—obesity	2.06e-06	3.53e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNAS—obesity	2.05e-06	3.52e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS1—obesity	2.05e-06	3.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—obesity	2.05e-06	3.52e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—obesity	2.05e-06	3.52e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—obesity	2.04e-06	3.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—obesity	2.04e-06	3.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—obesity	2.04e-06	3.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C3—obesity	2.04e-06	3.5e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CAV1—obesity	2.02e-06	3.48e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOA1—obesity	2.02e-06	3.47e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOB—obesity	2.01e-06	3.45e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNAS—obesity	2e-06	3.44e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—obesity	1.98e-06	3.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—obesity	1.98e-06	3.39e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—obesity	1.98e-06	3.39e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—COMT—obesity	1.97e-06	3.38e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INS—obesity	1.96e-06	3.37e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOB—obesity	1.96e-06	3.37e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—obesity	1.95e-06	3.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—obesity	1.95e-06	3.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS2—obesity	1.94e-06	3.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—INS—obesity	1.94e-06	3.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNB3—obesity	1.94e-06	3.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARGC1A—obesity	1.94e-06	3.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—obesity	1.94e-06	3.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—obesity	1.93e-06	3.32e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—obesity	1.93e-06	3.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—obesity	1.93e-06	3.31e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—obesity	1.93e-06	3.31e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRKCB—obesity	1.93e-06	3.31e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LPL—obesity	1.92e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—obesity	1.92e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—obesity	1.92e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BAD—obesity	1.9e-06	3.27e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—obesity	1.9e-06	3.26e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT2—obesity	1.9e-06	3.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—obesity	1.9e-06	3.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—obesity	1.9e-06	3.26e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNAS—obesity	1.89e-06	3.24e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—obesity	1.88e-06	3.23e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOA1—obesity	1.88e-06	3.22e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LPL—obesity	1.87e-06	3.22e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—obesity	1.87e-06	3.21e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOB—obesity	1.85e-06	3.17e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.84e-06	3.17e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—obesity	1.83e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—obesity	1.82e-06	3.13e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—obesity	1.82e-06	3.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS1—obesity	1.82e-06	3.13e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—obesity	1.81e-06	3.11e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	1.81e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—obesity	1.8e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—obesity	1.8e-06	3.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—obesity	1.79e-06	3.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCB—obesity	1.79e-06	3.07e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—obesity	1.78e-06	3.06e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—obesity	1.78e-06	3.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—obesity	1.78e-06	3.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BAD—obesity	1.77e-06	3.04e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LPL—obesity	1.76e-06	3.03e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TYK2—obesity	1.75e-06	3.01e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—obesity	1.75e-06	3.01e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—obesity	1.75e-06	3.01e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INS—obesity	1.74e-06	3e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RHOA—obesity	1.74e-06	2.99e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—obesity	1.73e-06	2.97e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3R1—obesity	1.72e-06	2.96e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—obesity	1.72e-06	2.96e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—obesity	1.72e-06	2.96e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—obesity	1.72e-06	2.95e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.71e-06	2.94e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—obesity	1.7e-06	2.92e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3R1—obesity	1.7e-06	2.92e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARA—obesity	1.69e-06	2.91e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS1—obesity	1.69e-06	2.91e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—obesity	1.69e-06	2.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT2—obesity	1.69e-06	2.9e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—obesity	1.69e-06	2.9e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—obesity	1.68e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—obesity	1.67e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARA—obesity	1.65e-06	2.84e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—obesity	1.64e-06	2.82e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—obesity	1.64e-06	2.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—obesity	1.63e-06	2.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INS—obesity	1.62e-06	2.78e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.62e-06	2.78e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK8—obesity	1.62e-06	2.78e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—obesity	1.61e-06	2.77e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—obesity	1.61e-06	2.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.6e-06	2.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.6e-06	2.75e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—obesity	1.6e-06	2.75e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—obesity	1.59e-06	2.74e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—obesity	1.59e-06	2.74e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.59e-06	2.73e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—obesity	1.59e-06	2.73e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOA1—obesity	1.59e-06	2.73e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—obesity	1.59e-06	2.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—obesity	1.57e-06	2.7e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—obesity	1.57e-06	2.7e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—obesity	1.57e-06	2.69e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT2—obesity	1.57e-06	2.69e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TYK2—obesity	1.56e-06	2.68e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARA—obesity	1.56e-06	2.68e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—obesity	1.55e-06	2.67e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—obesity	1.55e-06	2.67e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOA1—obesity	1.55e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RHOA—obesity	1.55e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.53e-06	2.63e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—obesity	1.53e-06	2.63e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.52e-06	2.61e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—obesity	1.51e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.51e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.49e-06	2.56e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.49e-06	2.56e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—obesity	1.48e-06	2.54e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—obesity	1.48e-06	2.54e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—obesity	1.48e-06	2.54e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—obesity	1.47e-06	2.52e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOA1—obesity	1.46e-06	2.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.46e-06	2.5e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—obesity	1.45e-06	2.5e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—obesity	1.45e-06	2.49e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TYK2—obesity	1.45e-06	2.49e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RHOA—obesity	1.44e-06	2.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.42e-06	2.44e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—obesity	1.42e-06	2.44e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—obesity	1.42e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—obesity	1.41e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—obesity	1.41e-06	2.43e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—obesity	1.4e-06	2.41e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—obesity	1.38e-06	2.37e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—obesity	1.38e-06	2.37e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—obesity	1.38e-06	2.36e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—INS—obesity	1.37e-06	2.36e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—obesity	1.37e-06	2.36e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—obesity	1.37e-06	2.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.35e-06	2.33e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—obesity	1.35e-06	2.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK8—obesity	1.34e-06	2.31e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—INS—obesity	1.34e-06	2.3e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—obesity	1.34e-06	2.3e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—obesity	1.33e-06	2.29e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.31e-06	2.25e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—obesity	1.31e-06	2.25e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—obesity	1.31e-06	2.25e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—obesity	1.29e-06	2.22e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—obesity	1.29e-06	2.21e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—obesity	1.28e-06	2.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—obesity	1.27e-06	2.18e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—INS—obesity	1.26e-06	2.17e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—obesity	1.26e-06	2.16e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—obesity	1.24e-06	2.14e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—obesity	1.23e-06	2.11e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—obesity	1.23e-06	2.11e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—obesity	1.23e-06	2.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.22e-06	2.09e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3R1—obesity	1.2e-06	2.07e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—obesity	1.2e-06	2.07e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—obesity	1.2e-06	2.06e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK8—obesity	1.19e-06	2.05e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—obesity	1.19e-06	2.04e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3R1—obesity	1.18e-06	2.02e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—obesity	1.18e-06	2.02e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—obesity	1.17e-06	2.01e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—obesity	1.17e-06	2.01e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—obesity	1.16e-06	1.99e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—obesity	1.14e-06	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—obesity	1.14e-06	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—obesity	1.14e-06	1.96e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—obesity	1.11e-06	1.91e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK8—obesity	1.11e-06	1.91e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3R1—obesity	1.11e-06	1.9e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—obesity	1.11e-06	1.9e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—obesity	1.11e-06	1.9e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—obesity	1.1e-06	1.89e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—obesity	1.09e-06	1.87e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—obesity	1.09e-06	1.86e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—obesity	1.08e-06	1.85e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—obesity	1.03e-06	1.78e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—obesity	1.02e-06	1.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—obesity	1.01e-06	1.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—obesity	1.01e-06	1.74e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—obesity	1.01e-06	1.74e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—obesity	1.01e-06	1.74e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—obesity	9.69e-07	1.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—obesity	9.57e-07	1.64e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—obesity	9.54e-07	1.64e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—obesity	9.42e-07	1.62e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—obesity	9.4e-07	1.61e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—obesity	8.61e-07	1.48e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—obesity	8.58e-07	1.47e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—obesity	8e-07	1.37e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—obesity	7.92e-07	1.36e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—obesity	7.82e-07	1.34e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—obesity	7.62e-07	1.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—obesity	7.08e-07	1.22e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—obesity	7.03e-07	1.21e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—obesity	6.78e-07	1.16e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—obesity	6.62e-07	1.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—obesity	6.53e-07	1.12e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—obesity	6.23e-07	1.07e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—obesity	5.54e-07	9.51e-06	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—obesity	5.4e-07	9.28e-06	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—obesity	5.09e-07	8.75e-06	CbGpPWpGaD
